Bradley Merrill Thompson, Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in multiple publications regarding a recent FTC complaint against an app developer, charging that its app advertising made unsubstantiated claims of medical benefit.
Following is an excerpt from Reuters:
"We could well see FTC taking the primary enforcement role," said Bradley Merrill Thompson, a Washington D.C. - based attorney with the firm Epstein Becker & Green. That the FTC took action, rather than the U.S. Food and Drug Administration, represents an important shift, Thompson added.
Related links:
- MedCity News, 01/21/2015
- mHealth News, 01/21/2015
- HealthData Management, 01/21/2015
- Politico, 01/21/2015
- Reuters, 01/20/2015
- MobiHealth News, 01/20/2015